Expression of MiR-207 in Renal Tissue of Renal Fibrosis Rats and Its Correlation Analysis with Protein Expression of TGF-β1 and Smad3
Overview
Pharmacology
Toxicology
Affiliations
Objective: This study was designed to analyze the expression of miR-207 in renal tissue of renal fibrosis rats and its correlation with the protein expression of TGF-β1 and Smad3.
Materials And Methods: Rat models with renal fibrosis were established via unilateral ureteral obstruction (UUO). Then, the expression levels of miR-207, TGF-β1 and Smad3 in renal tissue of rats were intervened by over-expression vector miR-207 mimic, miR-207 inhibitor and TGF-β/Smad3 signal SIS3 free base, and the effect and mechanism of action of miR-207 on renal fibrosis were analyzed.
Results: In UUO models established in this study, the expression levels of fibrosis related factors TGF-β1, Smad3, Smad2, α-SMA, BMP-7, MMP7 and MMP9 were elevated, and staining results showed that evident fibrosis occurred in renal tissue of rats. Moreover, we also found that the miR-207 expression increased in UUO model rats. After inhibiting miR-207 expression, their degree of renal fibrosis also reduced significantly, and the expression levels of TGF-β1, Smad3, Smad2, α-SMA, BMP-7, MMP7 and MMP9 were inhibited. Besides, miR-207 had a positive correlation with TGF-β1/Smad3 expression. We designed a group of rats, and found that while miR-207 expression was up-regulated, TGF-β1/Smad3 signals were inhibited, and compared with those with up-regulation of miR-207 expression, the severity of renal fibrosis reduced significantly, and the expression of other fibrosis indicators Smad2, α-SMA, BMP-7, MMP7 and MMP9 also reduced dramatically.
Conclusions: The miR-207 expression in renal tissue of rats with renal fibrosis increased, which was positively correlated with TGF-β1/Smad3, and miR-207 could promote the progression of renal fibrosis through TGF-β1/Smad3 signals.
Baicalein improves renal interstitial fibrosis by inhibiting the ferroptosis and .
Liang G, Mu W, Jiang C Heliyon. 2024; 10(7):e28954.
PMID: 38601597 PMC: 11004807. DOI: 10.1016/j.heliyon.2024.e28954.
Liang Q, Pan F, Qiu H, Zhou X, Cai J, Luo R Heliyon. 2024; 10(3):e24984.
PMID: 38333829 PMC: 10850413. DOI: 10.1016/j.heliyon.2024.e24984.
Zhu Y, Wang L, Liu R, Ding X, Yin S, Chen Y FEBS Open Bio. 2023; 13(10):1859-1873.
PMID: 37525933 PMC: 10549220. DOI: 10.1002/2211-5463.13684.
Huang J, Cao Y, Li X, Yu F, Han X Toxicol Res (Camb). 2022; 11(6):940-950.
PMID: 36569483 PMC: 9773066. DOI: 10.1093/toxres/tfac071.
Wang C, Wu S, Li J, Ma Y, Huang Y, Fang N Transl Androl Urol. 2022; 11(6):859-866.
PMID: 35812190 PMC: 9262747. DOI: 10.21037/tau-22-366.